Marker Therapeutics Provides Updates of its Lead Clinical Programs
Go back to Marker Therapeutics Provides Updates of its Lead Clinical Programs| (NASDAQ: MRKR) | Delayed: 1.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.33 | 52 Week High | $ | |||
| Open | $1.33 | 52 Week Low | $ | |||
| Day High | $1.33 | P/E | N/A | |||
| Day Low | $1.33 | EPS | $ | |||
| Volume | 12,940 | |||||
